9I�� News - Samira Sakhia

Supporting Desautels student leadership aspirations

webfull — Mon, 30 Aug 2021 15:17:51 +0000

While leading a pharmaceutical company, Samira Sakhia (BCom’90, DPA’94, MBA’01) is also volunteering her expertise in the broader 9I�� community and supporting students in realizing their leadership potential through the Samira Sakhia MBA Leadership Award.

Learn more

Published: 30 August 2021

Desautels alumna becomes President & CEO of Knight Therapeutics Inc.

webfull — Fri, 21 May 2021 17:42:37 +0000

Congratulations to Samira Sakhia (BCom’90, DPA’94, MBA’01), who will take on a new challenge as President and Chief Executive Officer of Knight Therapeutics Inc., a Montreal-based company focused on acquiring or in-licensing and commercializing innovative pharmaceutical products for Canada and Latin America. Sakhia brings more than 20 years of leadership experience in the pharmaceutical industry to the role.

Published: 21 May 2021

Announcement of Knight Therapeutics CFO resignation

webfull — Wed, 11 Oct 2017 15:54:32 +0000

Knight Therapeutics has announced the resignation of its chief financial officer, as the company’s president and Desautels International Faculty Advisory Board member, Samira Sakhia (BCom’90, DPA’94, MBA’01), takes on the additional responsibility of CFO.

In doing so, Sakhia will leverage her 14 years of prior experience as CFO for Paladin Labs Inc.

Published: 11 October 2017

Samira Sakhia to present at investor conference

webfull — Thu, 27 Apr 2017 18:16:47 +0000

At the Bloom Burton & Co Healthcare Investor Conference this May, Knight Therapeutics’ president, Samira Sakhia (BCom’90, DPA’94, MBA’01) will be giving the Montreal-based specialty pharmaceutics company’s corporate update.

The event takes place at the Sheraton Centre Hotel at 11:30 on May 1. Those who won’t be at the event, but who are still interested in the presentation, can download a copy at the company’s website (gudknight.com).

Published: 27 April 2017

Profound appoints Desautels alumna to its Board of Directors

webfull — Wed, 08 Mar 2017 16:42:27 +0000

In its 2016 financial results press release, Mississauga-based Profound Medical announced the appointment of Samira Sakhia (BCom’90, MBA’01) to its Board of Directors. Ms. Sakhia is also a member of the Desautels International Advisory Board and serves as President of Knight Therapeutics. Prior to that, she was CFO of Paladin Labs, which she helped sell to Dublin-based pharma giant, Endo International.

Published: 8 March 2017

People on the Move (October 2016 Update)

webfull — Thu, 06 Oct 2016 15:47:48 +0000

Samira Sakhia, president of Knight Therapeutics, has joined Crescita Therapeutics Inc.’s board of directors. Prior to her current role, she was the chief financial officer of Paladin Labs. She holds a Bachelor of Commerce degree in Finance and Accounting and a Masters of Business Administration in Strategy and Marketing from 9I�� and is a Chartered Professional Accountant. Additionally, Dr. Henrich Guntermann and Klaus von Lindeiner have tendered their resignations as board members of the company.

Published: 6 October 2016

Crescita Therapeutics Announces Changes to the Board of Directors

webfull — Fri, 30 Sep 2016 17:00:56 +0000

Crescita Therapeutics Inc. (Crescita or the Company), a commercial dermatology company with a portfolio of over-the-counter and prescription products for the treatment and care of skin diseases and their symptoms, today announced that Samira Sakhia, President of Knight Therapeutics, has joined its board of directors. Prior to her current role, Ms. Sakhia was the Chief Financial Officer of Paladin Labs. Ms.

Published: 30 September 2016

People on the Move (August/September 2016)

webfull — Tue, 13 Sep 2016 18:40:38 +0000

A monthly roundup of ‘people on the move’ in Canada’s life science and biotech sectors.

...Samira Sakhia, former CFO of Paladin Labs Inc. , has joined the Knight Therapeutics Inc. team as president and as member of the company’s board of directors. Ms. Sakhia served as the CFO at Paladin (acquired by Endo International plc February 2014), from 2001 to 2015. She holds an MBA and a Bachelors of Commerce degree from 9I�� and is also a Chartered Professional Accountant.

Published: 13 September 2016

A Knight is Reborn

webfull — Fri, 19 Aug 2016 15:10:39 +0000

Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, today announced that Samira Sakhia, former CFO of Paladin Labs Inc. ("Paladin"), will be joining the Knight team as President and member of the Board of Directors. In her new role, beginning on August 31, 2016, Samira will report to Jonathan Ross Goodman, CEO of Knight.

Published: 19 August 2016

Nuvo Research® Announces Appointment to its Board of Directors

webfull — Tue, 03 Nov 2015 15:56:08 +0000

Nuvo Research Inc. (TSX:NRI) (Nuvo or the Company), a specialty pharmaceutical company with growing revenues and a diverse portfolio of topical and immunology products, today announced the appointment of Samira Sakhia to its Board of Directors.

Read full article: Dallas South News, November 3, 2015

Published: 3 November 2015

9I��������� News - Samira Sakhia